Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer

201794 citationsJournal Articlebronze Open Access

Authors

clinicaltrials.gov Identifier: NCT00114816.

Good health and well-being

Published in: JAMA Oncology

Volume 3, Issue 6, pp. 793-793

Field-Weighted Citation Impact: 2.92